Skip to main content
Equibles

Eric Sherb

CFO

Apimeds Pharmaceuticals US, Inc. (APUS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eric Sherb

Eric Sherb is recorded as CFO at Apimeds Pharmaceuticals US, Inc. (APUS). Apimeds Pharmaceuticals US, Inc. reported in an 8-K filed October 1, 2026 that Eric Sherb was appointed Chief Financial Officer, effective October 1, 2026.

“On September 30, 2026, the Board of Directors (the "Board") of the Company appointed Eric Sherb, age 40, as Chief Financial Officer of the Company, effective October 1, 2026.”
Apimeds Pharmaceuticals US, Inc. Form 8-K, filed October 1, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Apimeds Pharmaceuticals US, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.